BeOne Medicines
ONC
#694
Rank
โ‚น3.352 T
Marketcap
โ‚น29,188
Share price
-1.81%
Change (1 day)
49.40%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

EPS for BeOne Medicines (ONC)

EPS in 2025 (TTM): โ‚น59.27

According to BeOne Medicines's latest financial reports the company's current EPS (TTM) is โ‚น60.75. In 2024 the company made an earnings per share (EPS) of -โ‚น583.19.

EPS history for BeOne Medicines from 2015 to 2025

Annual EPS

Year EPS Change
2025 (TTM)โ‚น59.27-110.16%
2024-โ‚น583.19
2022-โ‚น1,81027.35%
2021-โ‚น1,422-19.96%
2020-โ‚น1,77620.81%
2019-โ‚น1,47031.52%
2018-โ‚น1,118417.57%
2017-โ‚น215.97-37.16%
2016-โ‚น343.70158.95%
2015-โ‚น132.73

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
-โ‚น22.43-136.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-โ‚น88.79-246.15%๐Ÿ‡บ๐Ÿ‡ธ USA